Last December, Xconomy’s annual Bay Area biotech forum assessed the election aftermath for the life sciences. This year, What’s Hot in Bay Area Biotech, will dive into topics shaping the healthcare landscape, such as gene editing, the microbiome, immunotherapy, neuroscience, and more.
Join us to hear how top researchers, executives, investors, and thought leaders are navigating the political upheaval while staying focused on creating new medicines and treatments, and improving public health. It’s all happening on Wednesday, December 6, at UCSF Mission Bay, home to QB3, the University of California’s hub for life science innovation and entrepreneurship.
Confirmed speakers include:
— Jeff Bluestone, President & CEO, Parker Institute for Cancer Immunotherapy; A.W. and Mary Margaret Clausen Distinguished Professor, UCSF
— Alex de Winter, Managing Director, GE Ventures
— Bob Nelsen, Co-founder & Managing Director, ARCH Venture Partners